多omics和机器学习驱动的CD8+ T细胞异质性得分用于头部和部状细胞癌
Di He1, Zhan Yang2, Tian Zhang1
1Department of Oral and Maxillofacial Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Molecular therapy. Nucleic acids
|March 3, 2025
概括
头部和部状细胞癌 (HNSCC) 的治疗具有挑战性. 研究人员将OLR1确定为关键基因,这表明simvastatin和pazopanib是针对OLR1进行改善HNSCC免疫治疗的潜在疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 头部和部状细胞癌 (HNSCC) 是异质的,复杂的治疗.
- CD8+ T 细胞在瘤免疫微环境和免疫治疗点中至关重要.
- 降低CD8+T细胞得分与HNSCC预后不佳相关.
研究的目的:
- 研究CD8+ T细胞在HNSCC中的作用,并确定新的治疗点.
- 根据CD8+ T细胞基因表达来区分HNSCC亚型,以进行个性化治疗.
- 探索OLR1作为免疫治疗反应的预测生物标志物,并确定潜在的OLR1抑制剂.
主要方法:
- 机器学习算法 (八种方法) 用于分析基因表达数据并识别关键基因.
- 对HNSCC组织和外围血液进行了单细胞和空间转录组分析.
- 进行了药物敏感性和分子对接研究,以确定潜在的抑制剂.
主要成果:
- 根据CD8+T细胞基因表达,HNSCC被分为"冷"和"热"瘤亚型,显示出不同的预后和免疫治疗反应.
- 确定了OLR1基因是关键的参与者,主要表达在巨细胞中,并调节HNSCC免疫微环境.
- OLR1表达水平可以预测免疫治疗反应. 鉴定出simvastatin和pazopanib是潜在的OLR1抑制剂.
结论:
- OLR1是HNSCC免疫微环境的显著调节器,也是免疫治疗的潜在生物标志物.
- 西姆瓦斯塔丁和帕佐帕尼布通过抑制OLR1.1,显示出作为HNSCC新型治疗剂的前景.
- 这些发现为HNSCC的个性化治疗策略提供了新的途径.
关键词:
CD8+ T 细胞 CD8+ T 细胞在HNSCC中,我们可以看到HNSCC.MT: 生物信息学 生物信息学一个OLR1一个OLR1机器学习是机器学习.多种主题的多种主题.精密疗法是指精确的治疗方法.更多相关视频
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
825
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
825
01:22T Cell Activation and Clonal Selection
623
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
623